NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX)
Post# of 231
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced that its Chairman and Chief Executive Officer, Rodney Varner, is scheduled to present at the 4th Annual Disruptive Growth Conference. ReedSmith is hosting the event, which features growth companies with disruptive technologies and business models across a variety of sectors, at its offices at 599 Lexington Avenue in New York City on September 4, 2019. The Genprex presentation is slated for 5:00 p.m. to 5:15 p.m. Eastern Time in Presentation Room A/B.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer